PMV Pharma Announces Pricing of Oversubscribed $50 Million Public Offering of Securities

PMV Pharma announced a public offering of 22.055 million shares of common stock and pre-funded warrants to purchase 19.9 million shares, along with accompanying warrants, expected to raise approximately $50.8 million gross proceeds. The offering is priced at $1.21 per share and is expected to close on or about September 2, 2026.